RTA Laboratuvarlari Biyolojik
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. engages in the research, development, and production of microbiology and molecular biology products in Turkey. It offers microbiology products, including petri dish, tube and bottle, chromogenic media, blood culture bottle, tuberculosis diagnostic, rapid test, microbiological stain, hygislide, surcheck media, membrane, paint… Read more
RTA Laboratuvarlari Biyolojik (RTALB) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.010x
Based on the latest financial reports, RTA Laboratuvarlari Biyolojik (RTALB) has a cash flow conversion efficiency ratio of 0.010x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (TL20.98 Million) by net assets (TL2.12 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
RTA Laboratuvarlari Biyolojik - Cash Flow Conversion Efficiency Trend (2010–2024)
This chart illustrates how RTA Laboratuvarlari Biyolojik's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
RTA Laboratuvarlari Biyolojik Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of RTA Laboratuvarlari Biyolojik ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Prodia Widyahusada Tbk PT
JK:PRDA
|
0.073x |
|
Youlife Group Inc. American Depositary Shares
NASDAQ:YOUL
|
N/A |
|
Hyundai E P
KO:089470
|
-0.028x |
|
Unictron Technologies Corp
TW:6792
|
0.073x |
|
Toung LoongTextile Mfg Co Ltd
TWO:4401
|
0.074x |
|
Powerwell Holdings Bhd
KLSE:0217
|
0.106x |
|
Kortek Corporation
KQ:052330
|
-0.006x |
|
Go Hub Capital Berhad
KLSE:0311
|
0.017x |
Annual Cash Flow Conversion Efficiency for RTA Laboratuvarlari Biyolojik (2010–2024)
The table below shows the annual cash flow conversion efficiency of RTA Laboratuvarlari Biyolojik from 2010 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | TL1.67 Billion | TL-84.45 Million | -0.051x | -212.98% |
| 2023-12-31 | TL1.62 Billion | TL72.41 Million | 0.045x | +120.12% |
| 2022-12-31 | TL632.74 Million | TL-140.82 Million | -0.223x | -211.06% |
| 2021-12-31 | TL343.23 Million | TL68.78 Million | 0.200x | +258.87% |
| 2020-12-31 | TL167.81 Million | TL9.37 Million | 0.056x | +35.39% |
| 2019-12-31 | TL86.69 Million | TL3.58 Million | 0.041x | +140.54% |
| 2018-12-31 | TL57.06 Million | TL-5.81 Million | -0.102x | -492.76% |
| 2017-12-31 | TL54.25 Million | TL1.41 Million | 0.026x | -54.53% |
| 2016-12-31 | TL50.20 Million | TL2.86 Million | 0.057x | -56.95% |
| 2015-12-31 | TL46.74 Million | TL6.18 Million | 0.132x | +92.92% |
| 2014-12-31 | TL37.64 Million | TL2.58 Million | 0.069x | -87.31% |
| 2013-12-31 | TL20.83 Million | TL11.26 Million | 0.541x | +165.77% |
| 2012-12-31 | TL10.99 Million | TL2.24 Million | 0.203x | +28.71% |
| 2011-12-31 | TL10.19 Million | TL1.61 Million | 0.158x | -34.75% |
| 2010-12-31 | TL11.46 Million | TL2.78 Million | 0.242x | -- |